Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05155709 |
Title | A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | TUR | ITA | ISR | HUN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Oregon Health Sciences University . | Portland | Oregon | 97239 | United States | Details | |
Texas Oncology Sammons Cancer Center Sammons Cancer Center (SC) | Dallas | Texas | 78246 | United States | Details | |
Novartis Investigative Site | Hong Kong | Hong Kong | Details | |||
Novartis Investigative Site | Budapest | 1085 | Hungary | Details | ||
Novartis Investigative Site | Beer Sheva | 8457108 | Israel | Details | ||
Novartis Investigative Site | Jerusalem | 9112001 | Israel | Details | ||
Novartis Investigative Site | Bologna | BO | 40138 | Italy | Details | |
Novartis Investigative Site | Alor Setar | Kedah | 05460 | Malaysia | Details | |
Novartis Investigative Site | Selangor | 68000 | Malaysia | Details | ||
Novartis Investigative Site | Izmir | 35340 | Turkey | Details |